Global Sickle Cell Disease Treatment Market Size, Status and Forecast 2021-2027

鎌状赤血球症治療の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Sickle Cell Disease Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR5231
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:92
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医薬品、ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥429,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥643,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥858,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、鎌状赤血球症治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(鎌状赤血球貧血、シックルベータサラセミア、シックルヘモグロビンC病)、用途別市場規模(病院、診療所、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・鎌状赤血球症治療の市場動向
・企業の競争状況、市場シェア
・鎌状赤血球症治療の種類別市場規模(鎌状赤血球貧血、シックルベータサラセミア、シックルヘモグロビンC病)
・鎌状赤血球症治療の用途別市場規模(病院、診療所、その他)
・鎌状赤血球症治療の北米市場規模2016-2027(アメリカ、カナダ)
・鎌状赤血球症治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・鎌状赤血球症治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・鎌状赤血球症治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・鎌状赤血球症治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(AstraZeneca、Eli Lilly、Novartis、Pfizer、Baxter、Emmaus Life Sciences、Bluebird bio、Blood Therapeutics、Sangamo Therapeutics、Acceleron Pharma、Arena Pharmaceuticals、Alnylam Pharmaceuticals)
・結論

Sickle cell disease is a group of disorders that affects hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body. People with this disorderhave atypical hemoglobin molecules called hemoglobin S, which can distort red blood cells into a sickle, or crescent, shape.

Market Analysis and Insights: Global Sickle Cell Disease Treatment Market
The global Sickle Cell Disease Treatment market size is projected to reach US$ 4132.3 million by 2026, from US$ 1920.2 million in 2019, at a CAGR of 11.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sickle Cell Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sickle Cell Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sickle Cell Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sickle Cell Disease Treatment market.

Global Sickle Cell Disease Treatment Scope and Market Size
Sickle Cell Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sickle Cell Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Sickle Cell Anemia
Sickle Beta Thalassemia
Sickle Hemoglobin C Disease

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Eli Lilly
Novartis
Pfizer
Baxter
Emmaus Life Sciences
Bluebird bio
Blood Therapeutics
Sangamo Therapeutics
Pfizer

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sickle Cell Anemia
1.2.3 Sickle Beta Thalassemia
1.2.4 Sickle Hemoglobin C Disease
1.3 Market by Application
1.3.1 Global Sickle Cell Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Sickle Cell Disease Treatment Market Perspective (2016-2027)
2.2 Sickle Cell Disease Treatment Growth Trends by Regions
2.2.1 Sickle Cell Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sickle Cell Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Sickle Cell Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Sickle Cell Disease Treatment Industry Dynamic
2.3.1 Sickle Cell Disease Treatment Market Trends
2.3.2 Sickle Cell Disease Treatment Market Drivers
2.3.3 Sickle Cell Disease Treatment Market Challenges
2.3.4 Sickle Cell Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Sickle Cell Disease Treatment Players by Revenue
3.1.1 Global Top Sickle Cell Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Sickle Cell Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Sickle Cell Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sickle Cell Disease Treatment Revenue
3.4 Global Sickle Cell Disease Treatment Market Concentration Ratio
3.4.1 Global Sickle Cell Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Disease Treatment Revenue in 2020
3.5 Sickle Cell Disease Treatment Key Players Head office and Area Served
3.6 Key Players Sickle Cell Disease Treatment Product Solution and Service
3.7 Date of Enter into Sickle Cell Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Sickle Cell Disease Treatment Breakdown Data by Type
4.1 Global Sickle Cell Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Sickle Cell Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Sickle Cell Disease Treatment Breakdown Data by Application
5.1 Global Sickle Cell Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Sickle Cell Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Sickle Cell Disease Treatment Market Size (2016-2027)
6.2 North America Sickle Cell Disease Treatment Market Size by Type
6.2.1 North America Sickle Cell Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Sickle Cell Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Sickle Cell Disease Treatment Market Size by Type (2016-2027)
6.3 North America Sickle Cell Disease Treatment Market Size by Application
6.3.1 North America Sickle Cell Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Sickle Cell Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Sickle Cell Disease Treatment Market Size by Application (2016-2027)
6.4 North America Sickle Cell Disease Treatment Market Size by Country
6.4.1 North America Sickle Cell Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Sickle Cell Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Sickle Cell Disease Treatment Market Size (2016-2027)
7.2 Europe Sickle Cell Disease Treatment Market Size by Type
7.2.1 Europe Sickle Cell Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Sickle Cell Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Sickle Cell Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Sickle Cell Disease Treatment Market Size by Application
7.3.1 Europe Sickle Cell Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Sickle Cell Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Sickle Cell Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Sickle Cell Disease Treatment Market Size by Country
7.4.1 Europe Sickle Cell Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Sickle Cell Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Sickle Cell Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Sickle Cell Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Sickle Cell Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sickle Cell Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sickle Cell Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Sickle Cell Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Sickle Cell Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sickle Cell Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sickle Cell Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Sickle Cell Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Sickle Cell Disease Treatment Market Size (2016-2027)
9.2 Latin America Sickle Cell Disease Treatment Market Size by Type
9.2.1 Latin America Sickle Cell Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Sickle Cell Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Sickle Cell Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Sickle Cell Disease Treatment Market Size by Application
9.3.1 Latin America Sickle Cell Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Sickle Cell Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Sickle Cell Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Sickle Cell Disease Treatment Market Size by Country
9.4.1 Latin America Sickle Cell Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Sickle Cell Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Sickle Cell Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Sickle Cell Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Sickle Cell Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sickle Cell Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sickle Cell Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Sickle Cell Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Sickle Cell Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sickle Cell Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sickle Cell Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Sickle Cell Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Sickle Cell Disease Treatment Introduction
11.1.4 AstraZeneca Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Sickle Cell Disease Treatment Introduction
11.2.4 Eli Lilly Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Sickle Cell Disease Treatment Introduction
11.3.4 Novartis Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Sickle Cell Disease Treatment Introduction
11.4.4 Pfizer Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Baxter
11.5.1 Baxter Company Details
11.5.2 Baxter Business Overview
11.5.3 Baxter Sickle Cell Disease Treatment Introduction
11.5.4 Baxter Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.5.5 Baxter Recent Development
11.6 Emmaus Life Sciences
11.6.1 Emmaus Life Sciences Company Details
11.6.2 Emmaus Life Sciences Business Overview
11.6.3 Emmaus Life Sciences Sickle Cell Disease Treatment Introduction
11.6.4 Emmaus Life Sciences Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.6.5 Emmaus Life Sciences Recent Development
11.7 Bluebird bio
11.7.1 Bluebird bio Company Details
11.7.2 Bluebird bio Business Overview
11.7.3 Bluebird bio Sickle Cell Disease Treatment Introduction
11.7.4 Bluebird bio Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.7.5 Bluebird bio Recent Development
11.8 Blood Therapeutics
11.8.1 Blood Therapeutics Company Details
11.8.2 Blood Therapeutics Business Overview
11.8.3 Blood Therapeutics Sickle Cell Disease Treatment Introduction
11.8.4 Blood Therapeutics Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.8.5 Blood Therapeutics Recent Development
11.9 Sangamo Therapeutics
11.9.1 Sangamo Therapeutics Company Details
11.9.2 Sangamo Therapeutics Business Overview
11.9.3 Sangamo Therapeutics Sickle Cell Disease Treatment Introduction
11.9.4 Sangamo Therapeutics Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.9.5 Sangamo Therapeutics Recent Development
11.10 Acceleron Pharma
11.10.1 Acceleron Pharma Company Details
11.10.2 Acceleron Pharma Business Overview
11.10.3 Acceleron Pharma Sickle Cell Disease Treatment Introduction
11.10.4 Acceleron Pharma Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.10.5 Acceleron Pharma Recent Development
11.11 Arena Pharmaceuticals
11.11.1 Arena Pharmaceuticals Company Details
11.11.2 Arena Pharmaceuticals Business Overview
11.11.3 Arena Pharmaceuticals Sickle Cell Disease Treatment Introduction
11.11.4 Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.11.5 Arena Pharmaceuticals Recent Development
11.12 Alnylam Pharmaceuticals
11.12.1 Alnylam Pharmaceuticals Company Details
11.12.2 Alnylam Pharmaceuticals Business Overview
11.12.3 Alnylam Pharmaceuticals Sickle Cell Disease Treatment Introduction
11.12.4 Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.12.5 Alnylam Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Sickle Cell Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Sickle Cell Anemia
Table 3. Key Players of Sickle Beta Thalassemia
Table 4. Key Players of Sickle Hemoglobin C Disease
Table 5. Global Sickle Cell Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Sickle Cell Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Sickle Cell Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Sickle Cell Disease Treatment Market Share by Regions (2016-2021)
Table 9. Global Sickle Cell Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Sickle Cell Disease Treatment Market Share by Regions (2022-2027)
Table 11. Sickle Cell Disease Treatment Market Trends
Table 12. Sickle Cell Disease Treatment Market Drivers
Table 13. Sickle Cell Disease Treatment Market Challenges
Table 14. Sickle Cell Disease Treatment Market Restraints
Table 15. Global Sickle Cell Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Sickle Cell Disease Treatment Market Share by Players (2016-2021)
Table 17. Global Top Sickle Cell Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell Disease Treatment as of 2020)
Table 18. Ranking of Global Top Sickle Cell Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Sickle Cell Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sickle Cell Disease Treatment Product Solution and Service
Table 22. Date of Enter into Sickle Cell Disease Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sickle Cell Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Sickle Cell Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Sickle Cell Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Sickle Cell Disease Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Sickle Cell Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Sickle Cell Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Sickle Cell Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Sickle Cell Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Sickle Cell Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Sickle Cell Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Sickle Cell Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Sickle Cell Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Sickle Cell Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Sickle Cell Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Sickle Cell Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Sickle Cell Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Sickle Cell Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Sickle Cell Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Sickle Cell Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Sickle Cell Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Sickle Cell Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Sickle Cell Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Sickle Cell Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Sickle Cell Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Sickle Cell Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Sickle Cell Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Sickle Cell Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Sickle Cell Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Sickle Cell Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Sickle Cell Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Sickle Cell Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Sickle Cell Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. AstraZeneca Company Details
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Sickle Cell Disease Treatment Product
Table 65. AstraZeneca Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 66. AstraZeneca Recent Development
Table 67. Eli Lilly Company Details
Table 68. Eli Lilly Business Overview
Table 69. Eli Lilly Sickle Cell Disease Treatment Product
Table 70. Eli Lilly Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 71. Eli Lilly Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Sickle Cell Disease Treatment Product
Table 75. Novartis Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Sickle Cell Disease Treatment Product
Table 80. Pfizer Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Baxter Company Details
Table 83. Baxter Business Overview
Table 84. Baxter Sickle Cell Disease Treatment Product
Table 85. Baxter Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 86. Baxter Recent Development
Table 87. Emmaus Life Sciences Company Details
Table 88. Emmaus Life Sciences Business Overview
Table 89. Emmaus Life Sciences Sickle Cell Disease Treatment Product
Table 90. Emmaus Life Sciences Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 91. Emmaus Life Sciences Recent Development
Table 92. Bluebird bio Company Details
Table 93. Bluebird bio Business Overview
Table 94. Bluebird bio Sickle Cell Disease Treatment Product
Table 95. Bluebird bio Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 96. Bluebird bio Recent Development
Table 97. Blood Therapeutics Company Details
Table 98. Blood Therapeutics Business Overview
Table 99. Blood Therapeutics Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 100. Blood Therapeutics Recent Development
Table 101. Sangamo Therapeutics Company Details
Table 102. Sangamo Therapeutics Business Overview
Table 103. Sangamo Therapeutics Sickle Cell Disease Treatment Product
Table 104. Sangamo Therapeutics Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 105. Sangamo Therapeutics Recent Development
Table 106. Acceleron Pharma Company Details
Table 107. Acceleron Pharma Business Overview
Table 108. Acceleron Pharma Sickle Cell Disease Treatment Product
Table 109. Acceleron Pharma Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 110. Acceleron Pharma Recent Development
Table 111. Arena Pharmaceuticals Company Details
Table 112. Arena Pharmaceuticals Business Overview
Table 113. Arena Pharmaceuticals Sickle Cell Disease Treatment Product
Table 114. Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 115. Arena Pharmaceuticals Recent Development
Table 116. Alnylam Pharmaceuticals Company Details
Table 117. Alnylam Pharmaceuticals Business Overview
Table 118. Alnylam Pharmaceuticals Sickle Cell Disease Treatment Product
Table 119. Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 120. Alnylam Pharmaceuticals Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sickle Cell Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Sickle Cell Anemia Features
Figure 3. Sickle Beta Thalassemia Features
Figure 4. Sickle Hemoglobin C Disease Features
Figure 5. Global Sickle Cell Disease Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Sickle Cell Disease Treatment Report Years Considered
Figure 10. Global Sickle Cell Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Sickle Cell Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Sickle Cell Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Sickle Cell Disease Treatment Market Share by Regions (2022-2027)
Figure 14. Global Sickle Cell Disease Treatment Market Share by Players in 2020
Figure 15. Global Top Sickle Cell Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell Disease Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Sickle Cell Disease Treatment Revenue in 2020
Figure 17. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Sickle Cell Disease Treatment Market Share by Type (2016-2027)
Figure 21. North America Sickle Cell Disease Treatment Market Share by Application (2016-2027)
Figure 22. North America Sickle Cell Disease Treatment Market Share by Country (2016-2027)
Figure 23. United States Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Sickle Cell Disease Treatment Market Share by Type (2016-2027)
Figure 27. Europe Sickle Cell Disease Treatment Market Share by Application (2016-2027)
Figure 28. Europe Sickle Cell Disease Treatment Market Share by Country (2016-2027)
Figure 29. Germany Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Sickle Cell Disease Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Sickle Cell Disease Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Sickle Cell Disease Treatment Market Share by Region (2016-2027)
Figure 39. China Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Sickle Cell Disease Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Sickle Cell Disease Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Sickle Cell Disease Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Sickle Cell Disease Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Sickle Cell Disease Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Sickle Cell Disease Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AstraZeneca Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 59. Eli Lilly Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 62. Baxter Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 63. Emmaus Life Sciences Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 64. Bluebird bio Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 65. Blood Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 66. Sangamo Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 67. Acceleron Pharma Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 68. Arena Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 69. Alnylam Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[鎌状赤血球症治療の世界市場規模・現状・予測2021年-2027年] (Global Sickle Cell Disease Treatment Market Size, Status and Forecast 2021-2027 / QY21APR5231)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆